Prime Medicine logo
PRMEPrime Medicine
Trade PRME now
Prime Medicine primary media

About Prime Medicine

Prime Medicine (NASDAQ:PRME) is a biotechnological company focused on harnessing the power of gene editing to develop treatments for serious diseases. The company's operations revolve around the innovative use of Prime Editing, a next-generation gene editing technology, aiming to correct genetic mutations at their source. Prime Medicine is dedicated to advancing its pipeline of projects targeting a wide range of diseases, with the objective of offering transformative therapeutic options to patients in need. The quest to bring novel therapies from the lab to the clinic underscores their commitment to addressing unmet medical needs.

What is PRME known for?

Snapshot

Public US
Ownership
2019
Year founded
276
Employees
Massachusetts, United States
Head office
1 of 5
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...

Operations

All Locations
United States

Produtos e/ou serviços de Prime Medicine

  • Prime Editing technology, a precise gene editing approach aiming to correct a broad range of genetic mutations.
  • Research into treatments for genetic disorders, utilizing prime editing to address diseases at their source.
  • Partnerships with biotech and pharmaceutical companies to advance gene editing applications and therapies.
  • Development of delivery mechanisms to efficiently target and edit genes within the human body.
  • Investment in a scalable platform for the manufacturing and distribution of genetic therapies.
  • Ongoing efforts in intellectual property expansion to secure and protect advancements in gene editing technology.

equipe executiva do Prime Medicine

  • Mr. Jeffrey D. Marrazzo M.B.A., M.P.A.Executive Chair
  • Dr. Allan Reine M.D.CEO & Director
  • Dr. Keith Michael Gottesdiener M.D., Ph.D.Consultant
  • Dr. Andrew Anzalone M.D., Ph.D.Co-Founder
  • Dr. David R. Liu Ph.D.Co-Founder & Member of Scientific Advisory Board
  • Dr. Ann L. Lee Ph.D.Chief Technical Officer
  • Mr. Ryan E. Brown J.D.Chief Legal Officer
  • Ms. Niamh AlixChief Human Resources Officer
  • Mr. Mohammed Asmal M.D., Ph.D.Senior VP & Head of Clinical
  • Dr. Matthew J. Hawryluk M.B.A., Ph.D.Chief Business Officer

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.